Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
PZ HTL SA

Partners to Develop Complex Multilayer Films for Biopharmaceutical Applications

By BiotechDaily International staff writers
Posted on 21 Jun 2011
Two European manufacturers have signed an exclusive cooperation agreement to develop, manufacture, and supply polymer plastic films for the biopharmaceutical market.

Sartorius Stedim Biotech (Aubagne, France) - a leading provider of equipment and services for development, quality assurance, and production processes in the biopharmaceutical industry - and Südpack Medica AG (Ochsenhausen, Germany) - a manufacturer of innovative packaging solutions that belongs to the Südpack Group - have agreed to form a strategic partnership for an initial term of 10 years.

Südpack will produce plastic film materials for Sartorius Stedim Biotech to be employed in the manufacture of single-use bags and systems. These single-use bags are primarily for laboratory applications by customers in the pharmaceutical industry for cell cultivation, transportation, and storage of biopharmaceutical liquids.

In addition, the two companies will collaborate on the development of novel multilayer films with improved product characteristics. The first product innovations from this cooperation are expected in approximately one year from now.

"Südpack Medica AG has already been developing and manufacturing packaging solutions for medical product manufacturers for many years. Cooperation with Sartorius Stedim Biotech is now an important step into the new, promising markets of the future. We are proud that Sartorius Stedim Biotech, one of the market leaders in the biotechnology industry, has selected us as a partner to jointly develop innovative film laminates. This also tells me that we are on the right track with our strategy of continuously investing in new technologies and developments," said Johannes Remmele, managing director of Südpack.

"Through the alliance with Südpack, we have gained an excellent partner for the development and manufacture of complex multi-layer films that we process in the production of our single-use bags. By supplying innovative single-use products, we are striving to continue offering our customers real added value in the future as well. For this reason, the strategic partnership with Südpack represents a key step for us," said Dr. Oscar-Werner Reif, executive vice president of research and development at Sartorius Stedim Biotech.

Related Links:
Sartorius Stedim Biotech
Südpack Medica AG


Channels

Genomics/Proteomics

view channel
Image: The TheraCyte cell encapsulation device (Photo courtesy of TheraCyte, Inc.).

Encapsulated Human-Insulin-Producing Progenitor Cells Cure Diabetes in Mouse Model

A breakthrough system that allows subcutaneous implantation of encapsulated immature pancreatic cells (beta progenitor cells) was shown to produce enough insulin to correct the symptoms of diabetes in a mouse model.... Read more

Drug Discovery

view channel
Image: Chitosan is derived from the shells of shrimp and other sea crustaceans, including Alaskan pink shrimp, pictured here (Photo courtesy of NOAA - [US] National Oceanic and Atmospheric Administration).

Chitosan Treatment Clears the Way for Antibiotics to Eliminate Recurrent Urinary Tract Infections

Recurrent urinary tract infection was successfully resolved in a mouse model by treatment with the exfoliant chitosan followed by a round of antibiotics. Bacterial urinary tract infection (UTI), most... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.